|

LUPKYNIS Drug-use Results Survey

RECRUITINGSponsored by Otsuka Pharmaceutical Co., Ltd.
Actively Recruiting
SponsorOtsuka Pharmaceutical Co., Ltd.
Started2025-09-17
Est. completion2031-06-30
Eligibility
Age15 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07053891

Summary

The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.

Eligibility

Age: 15 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients who are newly starting administration of LUPKYNIS for lupus nephritis

Exclusion Criteria:

\-

Conditions2

LupusLupus Nephritis

Browse More Trials

Lupus trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.